Cypre is a biotechnology company dedicated to working with therapeutic innovators to overcome drug resistance for cancer patients.

Our 3D Tumor Model Platform engineers the tumor microenvironment at high throughput and rapidly assays targeted drugs and cancer immunotherapy using high content imaging.

Our 3D Tumor Panel is available now through Charles River Labs. Rapidly screen your therapeutic assets today.

Company Information

April 20, 2022